PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SRTS vs. ORCL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SRTS and ORCL is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

SRTS vs. ORCL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sensus Healthcare, Inc. (SRTS) and Oracle Corporation (ORCL). The values are adjusted to include any dividend payments, if applicable.

0.00%100.00%200.00%300.00%400.00%SeptemberOctoberNovemberDecember2025February
-5.81%
385.64%
SRTS
ORCL

Key characteristics

Sharpe Ratio

SRTS:

0.32

ORCL:

1.48

Sortino Ratio

SRTS:

1.10

ORCL:

2.22

Omega Ratio

SRTS:

1.15

ORCL:

1.32

Calmar Ratio

SRTS:

0.35

ORCL:

2.77

Martin Ratio

SRTS:

1.57

ORCL:

8.06

Ulcer Index

SRTS:

17.51%

ORCL:

6.81%

Daily Std Dev

SRTS:

85.77%

ORCL:

37.28%

Max Drawdown

SRTS:

-87.51%

ORCL:

-84.19%

Current Drawdown

SRTS:

-63.19%

ORCL:

-9.26%

Fundamentals

Market Cap

SRTS:

$90.89M

ORCL:

$487.12B

EPS

SRTS:

$0.41

ORCL:

$4.09

PE Ratio

SRTS:

13.44

ORCL:

42.58

PEG Ratio

SRTS:

0.00

ORCL:

1.64

Total Revenue (TTM)

SRTS:

$28.74M

ORCL:

$54.93B

Gross Profit (TTM)

SRTS:

$17.33M

ORCL:

$38.41B

EBITDA (TTM)

SRTS:

$6.48M

ORCL:

$22.74B

Returns By Period

In the year-to-date period, SRTS achieves a -20.38% return, which is significantly lower than ORCL's 4.78% return.


SRTS

YTD

-20.38%

1M

-16.01%

6M

-14.97%

1Y

16.99%

5Y*

4.81%

10Y*

N/A

ORCL

YTD

4.78%

1M

8.15%

6M

27.30%

1Y

58.18%

5Y*

27.73%

10Y*

16.56%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SRTS vs. ORCL — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SRTS
The Risk-Adjusted Performance Rank of SRTS is 6060
Overall Rank
The Sharpe Ratio Rank of SRTS is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of SRTS is 6060
Sortino Ratio Rank
The Omega Ratio Rank of SRTS is 6161
Omega Ratio Rank
The Calmar Ratio Rank of SRTS is 6161
Calmar Ratio Rank
The Martin Ratio Rank of SRTS is 6262
Martin Ratio Rank

ORCL
The Risk-Adjusted Performance Rank of ORCL is 8686
Overall Rank
The Sharpe Ratio Rank of ORCL is 8585
Sharpe Ratio Rank
The Sortino Ratio Rank of ORCL is 8282
Sortino Ratio Rank
The Omega Ratio Rank of ORCL is 8484
Omega Ratio Rank
The Calmar Ratio Rank of ORCL is 9393
Calmar Ratio Rank
The Martin Ratio Rank of ORCL is 8888
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SRTS vs. ORCL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sensus Healthcare, Inc. (SRTS) and Oracle Corporation (ORCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SRTS, currently valued at 0.32, compared to the broader market-2.000.002.004.000.321.48
The chart of Sortino ratio for SRTS, currently valued at 1.10, compared to the broader market-6.00-4.00-2.000.002.004.006.001.102.22
The chart of Omega ratio for SRTS, currently valued at 1.15, compared to the broader market0.501.001.502.001.151.32
The chart of Calmar ratio for SRTS, currently valued at 0.35, compared to the broader market0.002.004.006.000.352.77
The chart of Martin ratio for SRTS, currently valued at 1.57, compared to the broader market-10.000.0010.0020.0030.001.578.06
SRTS
ORCL

The current SRTS Sharpe Ratio is 0.32, which is lower than the ORCL Sharpe Ratio of 1.48. The chart below compares the historical Sharpe Ratios of SRTS and ORCL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
0.32
1.48
SRTS
ORCL

Dividends

SRTS vs. ORCL - Dividend Comparison

SRTS has not paid dividends to shareholders, while ORCL's dividend yield for the trailing twelve months is around 0.92%.


TTM20242023202220212020201920182017201620152014
SRTS
Sensus Healthcare, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
ORCL
Oracle Corporation
0.92%0.96%1.44%1.57%1.38%1.48%1.72%1.68%1.52%1.56%1.56%1.07%

Drawdowns

SRTS vs. ORCL - Drawdown Comparison

The maximum SRTS drawdown since its inception was -87.51%, roughly equal to the maximum ORCL drawdown of -84.19%. Use the drawdown chart below to compare losses from any high point for SRTS and ORCL. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-63.19%
-9.26%
SRTS
ORCL

Volatility

SRTS vs. ORCL - Volatility Comparison

Sensus Healthcare, Inc. (SRTS) has a higher volatility of 46.31% compared to Oracle Corporation (ORCL) at 19.84%. This indicates that SRTS's price experiences larger fluctuations and is considered to be riskier than ORCL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025February
46.31%
19.84%
SRTS
ORCL

Financials

SRTS vs. ORCL - Financials Comparison

This section allows you to compare key financial metrics between Sensus Healthcare, Inc. and Oracle Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab